the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories
Japanese Korean Chinese

[Report]

Developments in Cancer Vaccine Industry

Published: 2007/09

Contact 24 hrs/day
Description

Table of Contents

1 EXECUTIVE SUMMARY

  • Research Scope and Methodology
    • Research Scope
    • Research Methodology
  • Industry Overview; Trends; and Key Findings
    • Industry Overview and Trends
    • Noteworthy Developments

2 TECHNOLOGY ADOPTION FACTOR ANALYSIS

  • Technology Primer
    • Cancer--A Malignant Malady
    • The Immune Escape of Cancer
    • Cancer Vaccines--An Introduction
    • Therapeutic Vaccines in the Spotlight--Waking up the Immune System to Treat Cancer
  • Technology and Industry Drivers; Challenges
    • Technology and Industry Drivers
    • Technology and Industry Barriers and Challenges
  • Strategic Evaluation of the Competitive Environment
    • A Strategic Evaluation of the Cancer Vaccine Space-SWOT Analysis
    • Key Collaborations and Corporate Deals in the Cancer Vaccine Sector--An Impact Analysis
    • Pipeline Insight--Cancer Vaccines in the Lead
  • Current Trends; Future Outlook; and Strategic Recommendations (Analyst' s Perspectives)
    • Cancer Vaccine Industry Trends-A Turbulent Path toward Success
    • Cancer Vaccine Future Outlook-From Pipeline to Approved Products
    • Strategic Recommendations--Converting Challenge to Success

3 ON-GOING R & D HIGHLIGHTS IN THE CANCER VACCINE SPACE

  • Corporate Profiles--World
    • From Cell-Lines to off-the-shelf Immunotherapies-Creating an Impact in Cancer Therapeutics--USA
    • Liposomal Vaccines-Leading the Way in NSCLC Therapeutics--USA
    • Vaccine to Attack the Pregnancy Hormone-A Novel Theme to Tame Cancer--USA
    • Yeast Vector-Based Vaccines-A Novel Paradigm of Cancer Vaccine Development--USA
    • RNA-Loaded Dendritic Cells--Paving the Way for a New Generation of Personalized Cancer Vaccines--USA
    • Consolidated Immunotherapeutic Technologies as a Dynamic Tool to Combat Cancer--Denmark
    • A Cocktail of Approaches to Wake up the Immune System against Cancer--USA
    • Viral Vector Vaccines Inspire a Robust Mechanism of Immunization against a Wide Spectrum of Cancer Indications--France
    • Multiantigen Viral Vector Vaccines-Generating Broader Immune Responses--USA
    • Listeria-Based Vaccines-A Potent Bacterium-Based Stimulation of Immune System--USA
    • Telomerase Targeting Vaccines-Inciting Optimism to Deliver Targeted Cancer Therapy--USA
  • Academic Profiles--USA
    • Encouraging Results Reveal Pioneering Pancreatic Cancer Treatment
    • Vaccine Strategy Aims at Molecular Targets for Head and Neck Cancer
    • Embryonic Stem Cells Suggest an Exciting Possibility toward Lung Cancer Treatment in Mice
    • Researchers Embark on a Novel Approach to Prevent Breast Cancer

4 INTELLECTUAL PROPERTY (IP) SCENARIO; KEY CONTACTS

  • The IP Scenario
    • Key Industry Patents
    • Key Academic Patents
  • Key Contacts
    • Key Industry Contacts
    • Key Academic Contacts

5 DECISION SUPPORT DATABASE TABLES

  • Database Tables
    • Pharmaceutical R&D Expenditure--World (2002 to 2012)
    • Mortality of Prostrate Cancer--World (2002 to 2012)
    • Mortality of Lung Cancer--World (2002 to 2012)
    • Incidence of Breast Cancer--World (2002 to 2012)
    • Incidence of Colon Rectum Cancer--World (2002 to 2012)
Description

[Report]
Developments in Cancer Vaccine Industry
Published: 2007/09
Published by : Technical Insights, Inc. Technical Insights, Inc.

Price:
US $ 6,500.00 Hard Copy & Web Access (Regional License)
US $ 6,000.00 Web Access (Regional License)
>
Product Code : TI57002
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.